Table 3.
Odds ratios (OR) with 95% confidence intervals (CIs) for NAFLD according to the presence of obesity
| Model | Without obesity |
With obesity |
|||||
|---|---|---|---|---|---|---|---|
| OR | 95% CI | P-value | OR | 95% CI | P-value | ||
| For sarcopenia | |||||||
| Men | Sarcopenia | 1.41 | 1.19–1.67 | <0.001 | 1.16 | 0.97–1.38 | 0.100 |
| VFO | 3.97 | 3.43–4.59 | <0.001 | 2.00 | 1.69–2.37 | <0.001 | |
| Diabetes | 2.14 | 1.74–2.64 | <0.001 | 2.75 | 2.14–3.54 | <0.001 | |
| High CRP | 1.18 | 0.95–1.46 | 0.13 | 1.63 | 1.28–2.06 | <0.001 | |
| Women | Sarcopenia | 1.59 | 1.40–1.90 | <0.001 | 1.07 | 0.82–1.39 | 0.620 |
| VFO | 5.43 | 4.53–6.42 | <0.001 | 3.33 | 2.58–4.30 | <0.001 | |
| Diabetes | 3.93 | 3.01–5.14 | <0.001 | 3.51 | 2.39–5.15 | <0.001 | |
| High CRP | 1.04 | 0.79–1.39 | 0.770 | 2.11 | 1.55–2.88 | <0.001 | |
| Menopause | 1.73 | 1.28–2.33 | <0.001 | 1.61 | 1.04–2.49 | 0.031 | |
| For myosteatosis | |||||||
| Men | Myosteatosis | 1.24 | 1.02–1.50 | 0.028 | 1.06 | 0.89–1.26 | 0.500 |
| VFO | 3.98 | 3.44–4.60 | <0.001 | 1.99 | 1.68–2.35 | <0.001 | |
| Diabetes | 2.18 | 1.77–2.68 | <0.001 | 2.75 | 2.14–3.54 | <0.001 | |
| High CRP | 1.18 | 0.95–1.46 | 0.130 | 1.64 | 1.29–2.08 | <0.001 | |
| Women | Myosteatosis | 1.23 | 1.04–1.46 | 0.017 | 0.92 | 0.70–1.20 | 0.540 |
| VFO | 5.33 | 4.51–6.31 | <0.001 | 3.30 | 2.56–4.26 | <0.001 | |
| Diabetes | 3.97 | 3.04–5.18 | <0.001 | 3.48 | 2.37–5.10 | <0.001 | |
| High CRP | 1.06 | 0.80–1.41 | 0.690 | 2.13 | 1.57–2.91 | <0.001 | |
| Menopause | 1.70 | 1.26–2.29 | <0.001 | 1.63 | 1.05–2.91 | 0.028 | |
| For sarcopenia with myosteatosis | |||||||
| Men | Sarcopenia with myosteatosis | 1.35 | 0.94–1.94 | 0.106 | 1.16 | 0.86–1.56 | 0.338 |
| VFO | 3.98 | 3.44–4.60 | <0.001 | 1.99 | 1.68–2.36 | <0.001 | |
| Diabetes | 2.14 | 1.76–2.68 | <0.001 | 2.75 | 2.13–3.54 | <0.001 | |
| High CRP | 1.18 | 0.95–1.46 | 0.129 | 1.63 | 1.29–2.07 | <0.001 | |
| Women | Sarcopenia with myosteatosis | 1.44 | 1.05–1.90 | 0.028 | 1.02 | 0.72–1.44 | 0.926 |
| VFO | 5.36 | 4.52–6.34 | <0.001 | 3.44 | 2.59–4.31 | <0.001 | |
| Diabetes | 3.99 | 3.05–5.21 | <0.001 | 3.50 | 2.38–5.14 | <0.001 | |
| High CRP | 1.06 | 0.80–1.41 | 0.696 | 2.10 | 1.54–2.87 | <0.001 | |
| Menopause | 1.66 | 1.30–2.11 | <0.001 | 1.70 | 1.18–2.46 | 0.005 | |
NAFLD, non-alcoholic fatty liver disease; VFO, visceral fat obesity; hsCRP, high sensitive C-reactive protein.
Adjusted for age, regular aerobic exercise, regular resistance exercise, VFO, diabetes, high CRP, menopausal status (only in women), and sarcopenia or myosteatosis.